[MYGN] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
06-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 59.71%
YoY- -419.23%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 145,200 93,200 164,000 195,100 186,300 215,400 216,600 -23.34%
PBT -43,700 -58,500 -131,100 -11,400 -22,300 -7,700 3,300 -
Tax -28,500 -3,000 -15,900 -3,100 -1,700 -3,400 -3,600 295.72%
NP -15,200 -55,400 -115,200 -8,300 -20,600 -4,200 6,900 -
Tax Rate - - - - - - 109.09% -
Total Cost 160,400 148,600 279,200 203,400 206,900 219,600 209,700 -16.32%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -10.47 -59.44 -70.24 -4.25 -11.06 -1.95 3.19 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.20 -0.74 -1.55 -0.11 -0.28 -0.06 0.09 -
EPS Diluted -0.20 -0.74 -1.55 -0.11 -0.28 -0.06 0.09 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.